Fifth Third Bancorp’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Sell
42,791
-333
-0.8% -$92.6K 0.02% 418
2026
Q1
$11.7M Buy
43,124
+23,227
+117% +$6.64M 0.02% 416
2025
Q4
$5.73M Sell
19,897
-1,040
-5% -$291K 0.02% 300
2025
Q3
$5.44M Sell
20,937
-1,295
-6% -$325K 0.02% 308
2025
Q2
$5.52M Sell
22,232
-2,390
-10% -$591K 0.02% 299
2025
Q1
$6.52M Sell
24,622
-1,706
-6% -$454K 0.02% 278
2024
Q4
$6.68M Sell
26,328
-31
-0.1% -$8.35K 0.02% 277
2024
Q3
$7.44M Sell
26,359
-337
-1% -$93.6K 0.03% 273
2024
Q2
$7.1M Sell
26,696
-144
-0.5% -$37.8K 0.03% 271
2024
Q1
$7.26M Sell
26,840
-3,171
-11% -$833K 0.03% 273
2023
Q4
$7.52M Sell
30,011
-2,887
-9% -$684K 0.03% 264
2023
Q3
$7.73M Buy
32,898
+4,024
+14% +$981K 0.04% 256
2023
Q2
$7.07M Sell
28,874
-17,856
-38% -$4.34M 0.03% 273
2023
Q1
$11.1M Sell
46,730
-2,328
-5% -$560K 0.05% 235
2022
Q4
$12.2M Sell
49,058
-124
-0.3% -$30.1K 0.06% 225
2022
Q3
$11M Sell
49,182
-2,410
-5% -$575K 0.06% 225
2022
Q2
$12.2M Buy
51,592
+19,728
+62% +$4.76M 0.06% 220
2022
Q1
$8.11M Sell
31,864
-292
-0.9% -$72.1K 0.03% 287
2021
Q4
$8.57M Sell
32,156
-1,141
-3% -$291K 0.03% 288
2021
Q3
$8.23M Buy
33,297
+78
+0.2% +$20K 0.04% 281
2021
Q2
$8.21M Buy
33,219
+5,860
+21% +$1.4M 0.04% 281
2021
Q1
$6.26M Sell
27,359
-439
-2% -$101K 0.03% 312
2020
Q4
$6.22M Sell
27,798
-1,237
-4% -$264K 0.03% 297
2020
Q3
$5.92M Sell
29,035
-737
-2% -$149K 0.03% 294
2020
Q2
$5.74M Sell
29,772
-1,920
-6% -$360K 0.03% 294
2020
Q1
$5.26M Buy
31,692
+1,980
+7% +$362K 0.04% 274
2019
Q4
$5.7M Buy
29,712
+419
+1% +$75.1K 0.03% 297
2019
Q3
$4.91M Sell
29,293
-2,889
-9% -$494K 0.03% 303
2019
Q2
$5.6M Sell
32,182
-526
-2% -$88.8K 0.03% 289
2019
Q1
$5.64M Sell
32,708
-5,882
-15% -$997K 0.04% 277
2018
Q4
$6.2M Buy
38,590
+2,600
+7% +$441K 0.05% 252
2018
Q3
$6.49M Buy
35,990
+3,107
+9% +$534K 0.04% 266
2018
Q2
$5.23M Sell
32,883
-84
-0.3% -$13.2K 0.04% 275
2018
Q1
$5.06M Buy
32,967
+309
+0.9% +$49.3K 0.03% 278
2017
Q4
$5.03M Buy
32,658
+2,018
+7% +$310K 0.03% 280
2017
Q3
$4.67M Buy
30,640
+1,690
+6% +$252K 0.03% 286
2017
Q2
$4.27M Sell
28,950
-13,380
-32% -$1.89M 0.03% 289
2017
Q1
$5.83M Sell
42,330
-1,381
-3% -$186K 0.04% 262
2016
Q4
$5.54M Buy
43,711
+25,952
+146% +$3.31M 0.04% 270
2016
Q3
$2.36M Buy
17,759
+9,988
+129% +$1.35M 0.02% 375
2016
Q2
$1.01M Sell
7,771
-408
-5% -$52.3K 0.01% 525
2016
Q1
$1.01M Buy
8,179
+1,366
+20% +$166K 0.01% 541
2015
Q4
$905K Sell
6,813
-3,297
-33% -$430K 0.01% 562
2015
Q3
$1.24M Buy
10,110
+491
+5% +$67.3K 0.01% 509
2015
Q2
$1.35M Sell
9,619
-4,700
-33% -$649K 0.01% 523
2015
Q1
$1.94M Buy
14,319
+6,117
+75% +$806K 0.02% 459
2014
Q4
$1.03M Buy
8,202
+3,410
+71% +$419K 0.01% 580
2014
Q3
$561K Buy
4,792
+725
+18% +$83.1K 0.01% 688
2014
Q2
$454K Buy
4,067
+548
+16% +$58.6K ﹤0.01% 748
2014
Q1
$376K Buy
3,519
+704
+25% +$74.5K ﹤0.01% 777
2013
Q4
$285K Buy
2,815
+563
+25% +$55.2K ﹤0.01% 840
2013
Q3
$210K Buy
2,252
+164
+8% +$15.1K ﹤0.01% 879
2013
Q2
$180K Buy
+2,088
New +$180K ﹤0.01% 917

Other funds holding VHT

Fifth Third Bancorp's VHT Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Vanguard Health Care ETF (VHT) stake by 0.77% in Q2 2026, selling an estimated $92.6K and leaving 42,791 shares worth $12.8M. The position accounts for 0.02% of the portfolio, ranked #418.

Fifth Third Bancorp first reported a position in VHT in Q2 2013 and has held it in 53 quarters since. 1,112 funds tracked by Wall St. Rank hold VHT as of Q2 2026.

  • Fifth Third Bancorp held 42,791 shares of Vanguard Health Care ETF worth $12.8M as of Q2 2026.
  • Fifth Third Bancorp sold 333 Vanguard Health Care ETF shares in Q2 2026, an estimated $92.6K.
  • Vanguard Health Care ETF made up 0.02% of Fifth Third Bancorp's portfolio in Q2 2026, its #418 holding.
  • Fifth Third Bancorp first reported a position in Vanguard Health Care ETF in Q2 2013 and has held it in 53 quarters since.
  • 1,112 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.